The electroclinical features and surgical outcomes of inferior perisylvian epilepsy

Epilepsy Behav. 2021 Aug;121(Pt A):108028. doi: 10.1016/j.yebeh.2021.108028. Epub 2021 May 28.

Abstract

Objective: To summarize the clinical and electrophysiological observations of epilepsy originating from the inferior perisylvian cortex, and analyze the potential epileptic networks underlying the semiological manifestations.

Methods: We retrospectively analyzed patients with refractory inferior perisylvian epilepsy (IPE) who had undergone resective surgery, and then reviewed the demographic, clinical, neuroelectrophysiological, neuroimaging, surgical, histopathological, and follow-up data of the patients from the respective medical records. The selected patients were then categorized in accordance with the results of semiological analysis. Quantitative 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) analysis was performed to investigate the underlying neural network.

Results: Of the 18 IPE patients assessed in this study, ipsilateral frontotemporal epileptic discharges or its onsets were the dominant interictal or ictal scalp EEG observations. In addition, oroalimentary or manual automatism was the most frequently documented manifestation, followed by facial tonic or clonic movements. Moreover, the semiological analysis identified and classified the patients into 2 patterns, and the PET statistical analyses conducted on these 2 groups revealed differences in the neural network between them.

Conclusion: Inferior perisylvian epilepsy possesses semiological manifestations similar to those of mesial temporal lobe epilepsy or rolandic opercular epilepsy, hence these conditions should be carefully differentiated. Performing lesionectomy or cortectomy, sparing the mesial temporal structures, was found to be an effective and safe treatment modality for IPE.

Keywords: FDG-PET; Perisylvian epilepsy; SEEG; Superior temporal gyrus/sulcus; Temporal neocortical epilepsy.

MeSH terms

  • Electroencephalography
  • Epilepsy, Frontal Lobe*
  • Epilepsy, Temporal Lobe*
  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging
  • Positron-Emission Tomography
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18